BAX

Baxter Intl
NYSE

Real-time Quotes | Nasdaq Last Sale

82.97
+0.65
+0.79%
After Hours: 82.97 0 0.00% 16:58 09/18 EDT
OPEN
82.16
PREV CLOSE
82.32
HIGH
83.79
LOW
82.16
VOLUME
5.50M
TURNOVER
--
52 WEEK HIGH
95.19
52 WEEK LOW
69.10
MARKET CAP
42.00B
P/E (TTM)
59.23
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average BAX stock price target is 96.25 with a high estimate of 105.00 and a low estimate of 90.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BAX
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.